Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01X
- Chemical subgroupJ01XB
- Chemical substanceJ01XB02Polymyxin b
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 141 registrations
- Polymyxin B for Injection USP50 MG / VIAL · Powder For Solution · Sterimax INC
- Antibiotic Cream for Kids0.25 MG / G + 50 MG / G + 10000 UNIT / G · Cream · Taro Pharmaceuticals INC
- Antibiotic Ointment USP500 UNIT / G + 10000 UNIT / G · Ointment · Taro Pharmaceuticals INC
- Antibiotic Plus Pain Relief Cream0.25 MG / G + 50 MG / G + 10000 UNIT / G · Cream · Taro Pharmaceuticals INC
United States
FDA · 67 registrations
At a glance
- ATC code
- J01XB02
- ATC group
- Anti-infectives for systemic use
- Registers
- 10
- Historical lists
- 2
- Registrations
- 314
- With their own page
- 161
- Companies
- 151
All medicines with Polymyxin b
Human medicines from every register that match Polymyxin b by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
292 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Polymyxin B Sulfate | United States | 500,000 UNITS BASE/VIAL | injectable | Marketed | Hikma |
| Polymyxin B Sulfate | United States | 100,000,000 UNITS/BOT | powder | Not marketed | Paddock LLC |
| Polymyxin B for Injection USP | Canada | 50 MG / VIAL | Powder For Solution | Not marketed | Sterimax INC |
| Neomycin and Polymyxin B SulfateCombination | United States | 40MG BASE/ML; 200,000 UNITS/ML | solution | Marketed | Watson Labs |
| Trimethoprim Sulfate and Polymyxin B SulfateCombination | United States | 10,000 UNITS/ML; 1MG BASE/ML | solution/drops | Marketed | Bausch and Lomb INC |
| Bacitracin Zinc and Polymyxin B SulfateCombination | United States | 500 UNITS/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Neomycin and Polymyxin B Sulfates and GramicidinCombination | United States | 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML | solution/drops | Marketed | Watson Labs |
| Neomycin and Polymyxin B Sulfates and DexamethasoneCombination | United States | 0.1%; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Marketed | Sandoz |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | solution/drops | Marketed | Amneal |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Marketed | Sciegen Pharms |
| Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and HydrocortisoneCombination | United States | 400 UNITS/GM; 1%; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Terra-Cortril met polymyxine-B, oogzalfCombination | Netherlands | Oogzalf | Authorised | Pfizer B.V. | |
| Terra-Cortril met polymyxine-B, oorzalfCombination | Netherlands | Oorzalf | Authorised | Pfizer B.V. | |
| Neomycin and Polymyxin B Sulfates and Bacitracin ZincCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Bacitracin-Neomycin-PolymyxinCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 5,000 UNITS/GM | ointment | Not marketed | Pharmaderm |
| Terra-Cortril met polymyxine-B, oordruppelsCombination | Netherlands | Oordruppels, suspensie | Authorised | Euro Registratie Collectief B.V. | |
| Terra-Cortril met polymyxine-B, oordruppelsCombination | Netherlands | Oordruppels, suspensie | Authorised | Pfizer B.V. | |
| Terramycin W/ Polymyxin B SulfateCombination | United States | 5MG BASE/GM; 10,000 UNITS/GM | ointment | Not marketed | Casper Pharma LLC |
| Bacitracin Zinc-Polymyxin B SulfateCombination | United States | 500 UNITS/GM; 10,000 UNITS/GM | ointment | Not marketed | Naska |
| Bacitracin Zinc-Neomycin Sulfate-Polymyxin B SulfateCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 5,000 UNITS/GM | ointment | Not marketed | Naska |
| Bacitracin Zinc-Neomycin Sulfate-Polymyxin B SulfateCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Not marketed | Pharmafair |
| Neomycin Sulfate and Polymyxin B Sulfate GramicidinCombination | United States | 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML | solution/drops | Not marketed | Pharmafair |
| Neomycin Sulfate, Polymyxin B Sulfate & HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Not marketed | Pharmafair |
| Neomycin Sulfate-Polymyxin B Sulfate-HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Not marketed | Pharmafair |